Walgreens Boots Alliance, Inc.
WBA
$11.28
-$0.11-0.97%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
--
EPS (TTM)
Weiss Ratings | WBA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Risk Index | Very Weak | |||
Risk Grade | E+ | |||
Reward Grade | D | |||
Rating Factors | WBA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Excellent | |||
Growth Index | Weak | |||
Efficiency Index | Weak | |||
Solvency Index | Fair | |||
Total Return Index | Very Weak | |||
Volatility Index | Very Weak | |||
Beta / Standard Deviation | WBA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.42 | |||
Price History | WBA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.45% | |||
30-Day Total Return | -4.97% | |||
60-Day Total Return | 27.46% | |||
90-Day Total Return | 25.52% | |||
Year to Date Total Return | 22.74% | |||
1-Year Total Return | -42.98% | |||
2-Year Total Return | -62.56% | |||
3-Year Total Return | -71.46% | |||
5-Year Total Return | -69.64% | |||
52-Week High % Change | -48.34% | |||
52-Week Low % Change | 40.97% | |||
Price | WBA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $22.05 | |||
52-Week Low Price | $8.08 | |||
52-Week Low Price (Date) | Nov 21, 2024 | |||
52-Week High Price (Date) | Mar 28, 2024 | |||
Valuation | WBA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 9.84B | |||
Enterprise Value | 41.69B | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -10.24 | |||
Earnings Per Share Growth | -1,659.64% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.07 | |||
Price/Book (Q) | 0.99 | |||
Enterprise Value/Revenue (TTM) | 0.28 | |||
Price | $11.28 | |||
Enterprise Value/EBITDA (TTM) | 14.44 | |||
Enterprise Value/EBIT | 49.99 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | WBA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 863.80M | |||
Dividend Yield | 8.78% | |||
Div. Per Share (Most Recent) | $0.25 | |||
Dividend Per Share (TTM) | $1.00 | |||
Payout Ratio (TTM) | -12.01% | |||
Dividend Per Share (Most Recent) | $0.25 | |||
Company Info | WBA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 847 315 3700 | |||
Address | 108 Wilmot Road Deerfield, IL 60015 | |||
Website | www.walgreensbootsalliance.com | |||
Country | United States | |||
Year Founded | 1909 | |||
Profitability | WBA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 0.55% | |||
Profit Margin | -5.87% | |||
Management Effectiveness | WBA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 0.59% | |||
Return on Equity | -- | |||
Income Statement | WBA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 150.41B | |||
Total Revenue (TTM) | 150.41B | |||
Revenue Per Share | $174.12 | |||
Gross Profit (TTM) | 26.53B | |||
EBITDA (TTM) | 2.89B | |||
EBIT (TTM) | 834.00M | |||
Net Income (TTM) | -8.83B | |||
Net Income Avl. to Common (TTM) | -8.83B | |||
Total Revenue Growth (Q YOY) | 7.50% | |||
Earnings Growth (Q YOY) | -118.41% | |||
EPS Diluted (TTM) | -10.24 | |||
EPS Diluted Growth (Q YOY) | -287.50% | |||
Balance Sheet | WBA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.19B | |||
Cash Per Share (Q) | $1.38 | |||
Total Current Assets (Q) | 17.48B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 11.27B | |||
Current Ratio (Q) | 0.637 | |||
Book Value Per Share (Q) | $11.51 | |||
Total Assets (Q) | 78.54B | |||
Total Current Liabilities (Q) | 27.45B | |||
Total Debt (Q) | 31.71B | |||
Total Liabilities (Q) | 67.27B | |||
Total Common Equity (Q) | 9.94B | |||
Cash Flow | WBA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 1.72B | |||
Cash from Financing (TTM) | -2.41B | |||
Net Change in Cash (TTM) | 462.00M | |||
Levered Free Cash Flow (TTM) | 4.28B | |||
Cash from Operations (TTM) | 1.16B | |||